Pharmacokinetic Study in Patients With Unresectable Hepatocellular Carcinoma (HCC) Receiving Treatment With LifePearl Microspheres Loaded With Doxorubicin
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 28 Apr 2016
At a glance
- Drugs Doxorubicin (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Terumo
- 25 Apr 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
- 25 Apr 2016 Status changed from not yet recruiting to recruiting.
- 16 Sep 2015 New trial record